Add BrightSurf on Google Email

Johns Hopkins Medicine


Story Tip from Johns Hopkins experts on COVID-19

A new study by Johns Hopkins Medicine researchers found that mRNA vaccines for COVID-19 may provide protection against the latest variant strains and even the common cold. The vaccine-induced T cell response was found to be effective in recognizing the spike proteins of both SARS-CoV-2 and three common cold coronaviruses.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateApr 22, 2021

Story tips from Johns Hopkins experts on COVID-19

A recent Johns Hopkins Medicine study compared inpatient and outpatient surgical volumes during the pandemic and found significant declines, especially in regions hardest hit. Outpatient volumes recovered quickly, while inpatient volumes improved to near-pre-pandemic levels by September 2020.

SourceJohns Hopkins Medicine·JournalOpen Forum Infectious Diseases·DateApr 7, 2021

Johns Hopkins Medicine expert creates comprehensive guide to new diabetes drugs

A clinical practice review article by Rita Kalyani provides a systematic approach for treating patients with diabetes and cardiovascular disease. The article recommends using GLP-1 receptor agonists and SGLT2 inhibitors, particularly for patients with heart or blood vessel disease, to reduce the risk of major cardiovascular events.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateApr 7, 2021

Cancer immunotherapy approach targets common genetic alteration

Researchers developed a new cancer immunotherapy that uses engineered T cells to target a genetic alteration common among all cancers. The approach stimulates an immune response against cells with the loss of one gene copy, called loss of heterozygosity (LOH), and has shown promising results in laboratory studies and mouse models.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateMar 15, 2021

Story tips from Johns Hopkins experts on COVID-19

A Johns Hopkins Medicine-led study evaluating over 9,500 Orthodox Jews in 12 states identified key factors contributing to the spread of COVID-19 within culturally bonded groups. The findings informed the development of safety guidelines for COVID-19-free celebrations among Orthodox Jewish communities.

SourceJohns Hopkins Medicine·JournalJAMA Network Open·DateMar 10, 2021

Story tips from Johns Hopkins experts on Covid-19

A study published in JAMA Neurology suggests that large bone marrow cells called megakaryocytes may be responsible for the lingering aftereffects of severe COVID-19 cases, including brain fog. The researchers found evidence of megakaryocytes in the brains of patients who died from COVID-19 and believe they may reduce blood flow to the ...

SourceJohns Hopkins Medicine·JournalJAMA Neurology·DateFeb 24, 2021

Story tips from Johns Hopkins experts on Covid-19

A commentary by Johns Hopkins experts highlights the need for standardized data collection and analysis to inform policy decisions and strategies. They propose creating a consensus task force to define metrics and refine them over time, enabling public health leaders and healthcare organizations to identify effective solutions.

SourceJohns Hopkins Medicine·JournalJournal of Hospital Medicine·DateFeb 9, 2021

Gut microbe may promote breast cancers

A study from Johns Hopkins Medicine reveals that exposure to B. fragilis toxin can increase the risk of breast cancer by leaving a lasting impression on cells. Researchers found that breast tissue cells exposed to the toxin retained a long-term memory, leading to tumor growth and metastasis in mice.

SourceJohns Hopkins Medicine·JournalCancer Discovery·DateJan 6, 2021